Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
|
| Balance | $ 597,890 | $ 579,026 |
| Acquisitions (Note 4) | 136,301 | 19,096 |
| Currency translation | (1,524) | (232) |
| Balance | 732,667 | 597,890 |
| Protein Sciences [Member] | ||
| Balance | 347,918 | 331,789 |
| Acquisitions (Note 4) | 30,939 | 16,186 |
| Currency translation | (1,450) | (56) |
| Balance | 377,407 | 347,918 |
| Diagnostics and Genomics [Member] | ||
| Balance | 249,972 | 247,237 |
| Acquisitions (Note 4) | 105,362 | 2,910 |
| Currency translation | (74) | (176) |
| Balance | $ 355,260 | $ 249,972 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|